International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Funding and awards

Alexander Bilbily receives Sunnybrook's inaugural Innovation and Impact Award for Rho

Toronto. Sunnybrook Research Institute gave its first Innovation and Impact Award to Dr. Alexander Bilbily, 16 Bit's co-founder and co-CEO, for Rho, which Sunnybrook noted had regulatory authorization in Canada, the United States, Australia and Singapore and had screened more than 400,000 Canadians.

Sunnybrook ran Rho’s first prospective clinical study, published in the Canadian Association of Radiologists Journal in 2025. Dr. Bilbily is an affiliate scientist at Sunnybrook Research Institute, where he directs the Augmented Precision Medicine Lab, and an assistant professor at the University of Toronto.